<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Czech and Slovak Ophthalmology</journal-title>
      </journal-title-group>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">209</article-id>
      <article-id pub-id-type="doi">10.31348/2021/29</article-id>
      <article-categories>
        <subj-group>
          <subject>Case report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bilateral Amyloidosis of Three Eyelids. A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Krásný</surname>
            <given-names>Jan</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0341-0094</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Šach</surname>
            <given-names>Josef</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9287-7915</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hůlková</surname>
            <given-names>Helena</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pavlíček</surname>
            <given-names>Petr</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>15</day>
        <month>10</month>
        <year>2021</year>
      </pub-date>
      <issue>5</issue>
      <elocation-id>6</elocation-id>
      <abstract>
        <p>Aim: To present rare form of lids amyloidosis, in the context with literature and remind a Czech professor Vrabec, F., MD, an important pan-European ocular histologist. Case report: 37 years aged man was examined for eyelids mass on the department of ophthalmology of the Teaching Hospital Kralovske Vinohrady, Prague, Czech Republic in June 2018. The finding looked like chronic chalazion on the right side and chronic hordeolum on the left side. No acute phase was noted within last several months by the patient. Yellowish to lightly brown friable, partially transparent mass was obtained by excision. Amyloidosis of the AL type was revealed histologically, and diagnosis was followed by extended excision and plastic surgical reconstruction of the lower eyelids on both sides. No systemic disease underlying the amyloidosis was disclosed by following through diagnostic work-up of the patient. Results: Amyloidosis was illustrated initially by Congo red staining with characteristic dichroism in the polarized light, then it was analysed immunohistochemically, with positivity for kappa light chains. Systemic amyloidosis was excluded, as well as monoclonal gamapathy. Only slightly increased number of plasmacytes (up to 10 %) was revealed in the bone marrow biopsy. The surgical solution was optimal for the patient, and he was without any recurrence and problems of lower eyelids three years. Conclusion: Described case of bilateral eyelids amyloidosis without underlying systemic disease belongs to rare cases and also illustrates necessity of complex interdisciplinary cooperation in the diagnostic process.</p>
      </abstract>
      <kwd-group>
        <kwd>ocular amyloidosis</kwd>
        <kwd>palpebral mass</kwd>
        <kwd>plastic surgery of conjunctiva</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R5340">
        <mixed-citation>Duke-Elder S. System of Ophthalmogy, 1 st ed. London (Great Britain): H. Kimpton; 1963. Volume XIII, The ocular adnexa; 13-318.</mixed-citation>
      </ref>
      <ref id="R5341">
        <mixed-citation>Sedláček J. Prof. MUDr. František Vrabec, 65 let [prof. Vrabec Frantisek, MD, 65 years]. Cesk Oftalmol. 1976;22(6):475-476. Czech.</mixed-citation>
      </ref>
      <ref id="R5342">
        <mixed-citation>Krásný J, Dušek J, Vrabec F. Oční projevy při oxalóze [Ocular manifestations in oxalosis]. Cesk Oftalmol. 1985;41(4):258-262. Czech.</mixed-citation>
      </ref>
      <ref id="R5343">
        <mixed-citation>Kuchynka P, Vrabec F, Krásný J, Křepelková J. Vrozený defekt čočky u syndromu Pierre-Robina [Congenital defekt lenses in Pierre-Robin] Cesk Oftalmol. 1985;41(6):62-65. Czech.</mixed-citation>
      </ref>
      <ref id="R5344">
        <mixed-citation>Gertz MA, Rajmukar VS. Amyloidosis: Diagnosis and Treatment. Bos- ton (USA); Spriger Science and Businnes Medica; 2010. 238.</mixed-citation>
      </ref>
      <ref id="R5345">
        <mixed-citation>Ryšavá R. Systémové amyloidózy a jejich léčba [Systemic amyloidosis and their treatment] Praha (Czech Republic): Maxdorf; 2013. 135. Czech.</mixed-citation>
      </ref>
      <ref id="R5346">
        <mixed-citation>Knowles DM 2nd, Jakobiec FA, Rosen M, Howard G. Amyloidosis of the orbit and adnexae. Surv Ophthalmol. 1975;19(6):376-384.</mixed-citation>
      </ref>
      <ref id="R5347">
        <mixed-citation>Mora-Horna ER, Rojas-Padilla R, López VG, Guzmán MJ, Ceriotto A, Salcedo G. Ocular adnexal and orbital amyloidosis: a case series and literature review. Int Ophthalmol. 2016;36(2):281-291.</mixed-citation>
      </ref>
      <ref id="R5348">
        <mixed-citation>Leibovitch I, Selva D, Godberg RA, et al. Periocular and orbital amyloidosis: clinical characteristics management, and outcome. Ophthalmology. 2006;113(9):1657-1664.</mixed-citation>
      </ref>
      <ref id="R5349">
        <mixed-citation>Medel JR, Sánchez-Espaňa JC, Vasquez LM, et al. Orbital and peri- -orbital amyloidosis: A report of four cases. Orbit. 2018 Mar;22:1-6. doi:10.1080/01676830.2018.1449868<pub-id pub-id-type="doi">10.1080/01676830.2018.1449868</pub-id></mixed-citation>
      </ref>
      <ref id="R5350">
        <mixed-citation>Tyradellis C, Peponis V, Kulwin D. Surgical management of recurrent localized eyelid amyloidosis. Ophthalmic Plast Reconstr Surg. 2006;22(4):308-309.</mixed-citation>
      </ref>
      <ref id="R5351">
        <mixed-citation>Di Bari R, Guerriero S, Giancipoli G, Cantore A, Sborgia G, Piscitelli D. Primary localized orbital amyloidosis: a case report. Eur J Ophthalmol. 2006;16(6):895-897.</mixed-citation>
      </ref>
      <ref id="R5352">
        <mixed-citation>Reynolds MM, Veverka KK, Gertz MA, et al. Ocular manifestations of systematic amyloidosis. Retina. 2018;38(7):1371-1376.</mixed-citation>
      </ref>
      <ref id="R5353">
        <mixed-citation>Shah VS, Cavuoto KM, Capo H, Grace SF, Dubovy SR, Schatz NJ. Systemic amyloidosis and extraocular musle deposition. J Neuroophthalmol. 2016;36(2):167-173.</mixed-citation>
      </ref>
      <ref id="R5354">
        <mixed-citation>Krásný J, Šach J, Zikmund J. Merkel´s eyelid carcinoma – clinical histological study Cesk Slov Oftal. 2018;74(5):198-205. doi:10.31348/2018/5/5<pub-id pub-id-type="doi">10.31348/2018/5/5</pub-id></mixed-citation>
      </ref>
      <ref id="R5355">
        <mixed-citation>Naxer S, Behnes CL, Schitkowski MP. Amyloidosis. A rare differential diagnosis of an orbital tumor. Klin Monbl Augenheilkd. 2011;228(6):554-564.</mixed-citation>
      </ref>
      <ref id="R5356">
        <mixed-citation>have been successfully treated surgically. Surgical management of ptosis in younger patients aged 23 years [26] and 31 years [25] was cosmetically and functionally successful, even after five years in a single bilateral form. Another four bilateral lesions have been reported in eyelid ectropia [1], lacrimal duct stenosis [21] and twice in bulbar conjunctivae in the lower fornixes [20,21] out of a total of 19 patients from the 11 studies from 2002 to 2018. Systemic involvement was confirmed in only 2 patients (10%), namely infiltration of the semilunar lung</mixed-citation>
      </ref>
      <ref id="R5357">
        <mixed-citation>Demirci H, Shields CL, Eagle RC Jr, Shields JA. Conjuctival amyloidosis: report of six cases and review of the literature. Surv Ophthalmol. 2006;51(4):419-433.</mixed-citation>
      </ref>
      <ref id="R5358">
        <mixed-citation>Spitellie PH, Jordan DR, Gool P. Primary localized conjunctival amyloidosis simulating a lymphoproliferative disorder. Ophthal Plast Reconstr Surg. 2008;24(5):417-419.</mixed-citation>
      </ref>
      <ref id="R5359">
        <mixed-citation>Prager AJ, Habib AL, Gambogi T, Busam KJ, Marr BP. Long-term follow-up of 4 patients with conjuctival amyloidosis. Ocular Oncol Path. 2018;4:313-317. doi.orig/10.1159/000485918918<pub-id pub-id-type="doi">10.1159/000485918918</pub-id></mixed-citation>
      </ref>
      <ref id="R5360">
        <mixed-citation>Correa LJ, Maccio JP, Esposito E, et al. Systematic amyloidosis with bilateral conjunctival involvement: a case report. BMC Ophthalmol. 2015 Jul 19;15:77. doi:10.1186/s12886-015-0075-2<pub-id pub-id-type="doi">10.1186/s12886-015-0075-2</pub-id></mixed-citation>
      </ref>
      <ref id="R5361">
        <mixed-citation>Pirouzmand F, Hurwitz J, Howarth, D. Primary localized bilateral conjunctival amyloidosis and epiphora. Orbit. 2002;21(2):139-144.</mixed-citation>
      </ref>
      <ref id="R5362">
        <mixed-citation>Chakraborti C, Chaudhury KP, Biwas RR. Primary conjunctival amyloidosis. Oman J Ophthalmol. 2014;7(1):16-18.</mixed-citation>
      </ref>
      <ref id="R5363">
        <mixed-citation>and bilateral conjunctival [21]. Another localisation of amyloid deposition in the eye is associated with familial amyloid neuropathy with the transthyretin cys-114 mutation (TTR amyloidosis). Amyloid particles have been detected in the aqueous humour of secondary glaucoma, theoretically involving outflow obstruction as the mechanism of its formation [28]. This mutation was found in the bilateral in-traocular process of vitritis with bleeding and retinal vasculitis in five Indians, one of which was accompanied by bilateral secondary glaucoma in ocular symptoms [29]. A detailed examination of 54 patients with TTR amyloidosis always revealed bilateral ocular involvement in 24% of them, with a predominance of females. In all patients, the vitreous was affected, causing a de-crease in vision to an average of 0.2 and secondary glaucoma was 19%. It was caused 1 time by central venous occlusion, caused by intraocular amyloidosis [30]. With non-transthyretin familial amyloidosis, gelsolin-medi</mixed-citation>
      </ref>
      <ref id="R5364">
        <mixed-citation>Scuderi G, Abdolrahimzadeh S, Troccola A, Mazzocchi M, Recupero SM. Surgical treatment of a rare case of bilateral ptosis due to localized ocular amyloidosis. Saudi J Ophthalmol. 2016;30(3):201-203.</mixed-citation>
      </ref>
      <ref id="R5365">
        <mixed-citation>Garcia de Oteyza G, Ede la Paz M, Charoenrook de la Funte V. Unilateral tarzal amyloidosis. Arch Soc Esp Oftalmol. 2016;91(11):556- 558.</mixed-citation>
      </ref>
      <ref id="R5366">
        <mixed-citation>Kamal S, Goel R, Bodh SA. Primary localized amyloidosis presentig as a tarzal mass: report of two cases. Middle East Afr J Ophthalmol. 2012;19(4):426-428.</mixed-citation>
      </ref>
      <ref id="R5367">
        <mixed-citation>Nelson GA, Edward DP, Wilensky JT. Ocular amyloidosis and secondary glaucoma. Ophthalmology. 1999;106(7):1363-1366.</mixed-citation>
      </ref>
      <ref id="R5368">
        <mixed-citation>Venkatesh P, Selvan H, Singh SB, et al. Vitreous amyloidosis: ocular systemic and genetic insights. Ophthalmology. 2017;124(7):1014- 1022.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
